Small Caps Dashboard
 

PHARMAXIS


Sector: Biotech

Industry: Drug developer

Pharmaxis is an Australian pharmaceutical research company focussed on development drugs for inflammation and fibrotics diseases. The company has licenced two products: Bronchitol used to treat cystic fibrosis and marketed in Australia, Europe and Russia with US FDA approval pending; and Aridol, a lung function test for the assessment and diagnosis of asthma, marketed in Asia, Australia, Europe and US. The company has a pipeline of five drugs at various stages of development.

**FY20 Forecast

See our recomndations.
Unlock

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porttitor semper molestie. Ut eleifend, erat eu pulvinar iaculis, odio nunc venenatis tellus, ut placerat lorem purus sed tellus. Duis ut leo vitae massa facilisis dictum sed a dui. Proin quis pulvinar purus, vestibulum lobortis justo.

 
  • Radar Rating Unlock
  • Market Cap ($m)* 33.8
  • Dividend Yield (%)* 0
  • NET CASH ($M) 11
  • * Data as of 18 November 2021

Latest Research Summary

PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2020
05 Nov, 2020

Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas ut ex et est semper fringilla. Nam et lectus augue. Integer non consectetur ligula. Maecenas tortor metus, molestie at aliquam sit amet, feugiat sed ipsum. Donec vehicula mi ac neque tempor dignissim.

Unlock to view the latest research

Previous Research

Research Date Radar Rating  
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2020 05 Nov, 2020 9dd92bf4 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2020 15 Jul, 2020 46321faa View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2020 402 02 Jul, 2020 1d0b2c3f View Research
PHARMAXIS: RESEARCH TIP UPDATE - JANUARY 2020 16 Jan, 2020 f115c881 View Research
PHARMAXIS: RESEARCH TIP UPDATES - AUGUST 2019 21 Aug, 2019 5b1a9d62 View Research
PHARMAXIS: RESEARCH TIP UPDATES - MAY 2019 08 May, 2019 115e1339 View Research
PHARMAXIS: RESEARCH TIP UPDATES - FEBRUARY 2019 06 Feb, 2019 4d14300e View Research
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2018 21 Nov, 2018 6afe35e3 View Research
PHARMAXIS: RESEARCH TIP UPDATE - OCTOBER 2018 24 Oct, 2018 22fbad4c View Research
PHARMAXIS: RESEARCH TIP UPDATES - AUGUST 2018 08 Aug, 2018 6e3b77f6 View Research
PHARMAXIS: HEALTH AND BIOTECH - APRIL 2018 05 Apr, 2018 8d4a9e2a View Research
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2017 08 Nov, 2017 1d56afc4 View Research
PHARMAXIS: RESEARCH TIP UPDATE - SEPTEMBER 2017 14 Sep, 2017 406886f5 View Research
PHARMAXIS: REPORTING SEASON - AUGUST 2017 17 Aug, 2017 5e7be847 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2017 06 Jul, 2017 d06269fd View Research
PHARMAXIS: RESEARCH TIP UPDATE - JUNE 2017 15 Jun, 2017 a570df7a View Research
PHARMAXIS: RESEARCH TIP UPDATE - MAY 2017 18 May, 2017 be6ea133 View Research
PHARMAXIS: BIOTECH SPECIAL REPORT - FEBRUARY 2017 08 Feb, 2017 2cd8de46 View Research
PHARMAXIS: RESEARCH UPDATE - AUGUST 2016 25 Aug, 2016 4df642fb View Research
PHARMAXIS: INITIAL - MARCH 2016 29 Mar, 2016 a0e6d74d View Research
PHARMAXIS 25 Sep, 2014 c1a88d16 View Research
PHARMAXIS 22 Feb, 2014 795b27f4 View Research
PHARMAXIS 13 Jun, 2013 df6785ef View Research